Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
Not yet recruiting · NCT07636486 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Not yet recruiting | Phase 2 / Phase 3 | 2026-06-09 | NCT07636486 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 248 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Hematology, Nanfang Hospital, Southern Medical University | Guangzhou | China | 1 |